The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy

NCT01115218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2018-11-20

No results posted yet for this study

Summary

The aim of the study is to investigate whether it is possible to predict the success of trabeculectomy in patients with glaucoma through the examination of mediators of wound healing in anterior chamber fluid. The success rate of trabeculectomy with mitomycin C in the literature is about 75%. This leads on the question why 25% of the patients received trabeculectomy are not sufficient treated and have not a long-term IOP reduction. Precisely this question is to be examined by the study.

Conditions

Interventions

PROCEDURE

Trabeculectomy

Trabeculectomy with mitomycin C

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-01-31
Completion
2012-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115218 on ClinicalTrials.gov